Adam Torres and Robert Schultz discuss Sollievo Pharmaceutical’s new treatment.
Subscribe: iTunes / Spotify / Stitcher / RSS
Apply to be a guest on our podcast here
Show Notes:
In this episode, Adam Torres and Robert Schultz, Founder and CEO of Sollievo Pharmaceuticals, Inc., explore Sollievo Pharmaceutical’s new treatment. The company is developing a novel rapid-acting sedative to treat violent patients in the Emergency Department.
Apply to be a guest on our podcast here
Get the Mission Matters News FREE here
